Filing Details
- Accession Number:
- 0000886163-14-000074
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-10 16:29:29
- Reporting Period:
- 2014-06-09
- Filing Date:
- 2014-06-10
- Accepted Time:
- 2014-06-10 16:29:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
886163 | Ligand Pharmaceuticals Inc | LGND | Pharmaceutical Preparations (2834) | 770160744 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1605325 | J Melanie Herman | 11119 North Torrey Pines Road, Suite 200 La Jolla CA 92037 | Director Of Accounting | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-06-09 | 850 | $11.91 | 3,480 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-06-09 | 850 | $69.68 | 2,630 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2014-06-09 | 250 | $14.47 | 2,880 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-06-09 | 250 | $69.68 | 2,630 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-06-09 | 850 | $0.00 | 850 | $11.91 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-06-09 | 250 | $0.00 | 250 | $14.47 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,375 | 2022-01-03 | No | 4 | M | Direct | |
1,750 | 2022-02-09 | No | 4 | M | Direct |
Footnotes
- Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 01/03/12.
- Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/09/12.